Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -197,556 | -123,580 | -92,064 | -52,894 | -27,660 |
| Depreciation Amortization | -2,252 | -376 | 971 | 904 | 999 |
| Accounts payable and accrued liabilities | 12,706 | 1,507 | 369 | -250 | -290 |
| Other Working Capital | 10,008 | 2,671 | 416 | 418 | -243 |
| Other Operating Activity | 18,205 | 18,529 | 11,599 | 19,154 | 8,813 |
| Operating Cash Flow | $-158,889 | $-101,249 | $-78,709 | $-32,668 | $-18,381 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 96,942 | -385,081 | 59,705 | 10,415 | -70,065 |
| PPE Investments | -6,917 | -1,198 | -1,028 | -1,521 | -1,143 |
| Investing Cash Flow | $90,025 | $-386,279 | $58,677 | $8,894 | $-71,208 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,443 | 25,713 | 6,278 | 97,546 | 78,267 |
| Other Financing Activity | -312 | 398,594 | 52,410 | -642 | 0 |
| Financing Cash Flow | $6,131 | $424,307 | $58,688 | $96,904 | $78,267 |
| Beginning Cash Position | 82,152 | 145,373 | 106,717 | 33,587 | 44,909 |
| End Cash Position | 19,419 | 82,152 | 145,373 | 106,717 | 33,587 |
| Net Cash Flow | $-62,733 | $-63,221 | $38,656 | $73,130 | $-11,322 |
| Free Cash Flow | |||||
| Operating Cash Flow | -158,889 | -101,249 | -78,709 | -32,668 | -18,381 |
| Capital Expenditure | -6,917 | -1,198 | -1,028 | -1,521 | -1,143 |
| Free Cash Flow | -165,806 | -102,447 | -79,737 | -34,189 | -19,524 |